Organogenesis Holdings Inc. ORGO Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s investing cash flow?
- Organogenesis Holdings Inc. (ORGO) reported investing cash flow of -$3.15M in Q1 2026.
- How has Organogenesis Holdings Inc.'s investing cash flow changed year-over-year?
- Organogenesis Holdings Inc.'s investing cash flow increased by 13.2% year-over-year, from -$3.63M to -$3.15M.
- What is the long-term trend for Organogenesis Holdings Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Organogenesis Holdings Inc.'s investing cash flow has grown at a -17.9% compound annual growth rate (CAGR), from -$31.22M to -$14.15M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.